Index of artpub/2017/288968/

Socinski, Mark A
Phase 1/2 Study of the CD56-Targeting Antibody-Drug Conjugate Lorvotuzumab Mertansine (IMGN901) in Combination With Carboplatin/Etoposide in Small-Cell Lung Cancer Patients With Extensive-Stage Disease
2017
https://ddd.uab.cat/record/288968
[ICO]NameLast modifiedSizeDescription
[PARENTDIR]Parent Directory  -  
[ ]1=Socinski,_Mark_A2024-10-01 16:17 17  
[ ]2=Phase_1_2_Study_of_the_CD56-Targeting...2024-10-01 16:17 202  
[ ]3=20172024-10-01 16:17 5  
[ ]4=2889682024-10-01 16:17 34  
[TXT]288968.dirinfo2025-02-07 02:57 317  
[ ]288968.du2025-02-07 02:57 27  
[TXT]288968.dupdirs2025-02-07 02:57 0  
[TXT]288968.dupfiles2025-02-07 02:57 0  
[TXT]288968.errors2025-02-07 02:57 29  
[IMG]288968.gif2025-02-07 02:57 52K 
[IMG]288968.ico2025-02-07 02:57 12K 
[TXT]288968.info2025-02-07 02:57 38K 
[TXT]288968.md52025-02-07 02:57 45  
[ ]288968.pdf2025-02-07 02:57 474K 
[TXT]288968.sha12025-02-07 02:57 53  
[TXT]288968.sha2562025-02-07 02:57 77  
[TXT]288968.stats2025-02-07 02:57 269  
[TXT]288968.txt2025-02-07 02:57 0